US 11,666,760 B2
Cranial nerve stimulation to treat seizure disorders
Shivkumar Sabesan, Houston, TX (US); and Steven E. Maschino, Houston, TX (US)
Assigned to LivaNova USA, Inc., Houston, TX (US)
Filed by LivaNova USA, Inc., Houston, TX (US)
Filed on Mar. 29, 2021, as Appl. No. 17/216,251.
Application 17/216,251 is a continuation of application No. 16/184,789, filed on Nov. 8, 2018, abandoned.
Application 16/184,789 is a continuation of application No. 14/316,258, filed on Jun. 26, 2014, granted, now 10,124,169.
Claims priority of provisional application 61/840,461, filed on Jun. 28, 2013.
Claims priority of provisional application 61/888,303, filed on Oct. 8, 2013.
Prior Publication US 2021/0213289 A1, Jul. 15, 2021
Int. Cl. A61N 1/36 (2006.01)
CPC A61N 1/36064 (2013.01) [A61N 1/36053 (2013.01); A61N 1/36139 (2013.01); A61N 1/36178 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method comprising:
applying, by an implantable medical device (IMD), stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold; and
discontinuing the application of stimulation by the IMD when the level of synchrony exceeds a second threshold.